Attach 6E2 - Dalin Tsu-Chi Hospital_IRB_English

Office-head letter of Buddhist Dalin Tzu Chi General Hospital

IRB of Buddhist Dalin Tzu Chi General Hospital

Notification Letter of Review Result

Full title of project, version (including revised) and date	Title: “A Multi-Center International Hospital-Based Case-Control Study of Lymphoma in Asia(AsiaLymph): Taiwan Study Center” IRB number: A10004003 Version: Oct. 30, Minguo 101 version of the IRB
Title of other review documents, version(including revised) and date	Informed consent form related to genetic subjects: Jan. 18, Minguo 101 of the IRB Informed consent form: Jan. 18, Minguo 101 of the IRB
Principal Investigator	Yu-chieh Su
Approval date and place	Feb. 20, Minguo 101, IRB of Buddhist Dalin Tzu Chi General Hospital
Performance period and content	The performance period of “A Multi-Center International Hospital-Based Case-Control Study of Lymphoma in Asia(AsiaLymph): Taiwan Study Center”, the PI is Yu-chieh Su, will be Feb. 20, Minguo 101 to Feb. 19, Minguo 103 (about 3 years). The estimated enrolled subjects will be 180.
Active period of the approval	Feb. 20, Minguo 101 to Feb. 28, Minguo 102
Other additional suggestions	Periodic follow up review will be required, and will inform one week before the performance date. Please be cooperative at that time regarding the follow up review.
Regular follow-up process and requirement	In the middle of the project or when more than half of the subjects are enrolled, please provide mid-term report actively (it estimates that mid-term reports need to be submitted at the end of February of Minguo 102, and at the end of February of Minguo 103). A conclusion report is required to be submitted actively within two months after the completion of this project (It estimates that conclusion report will be submitted at the end of April of Minguo 104). No new project should be applied if this project does not be completed. If the project halts for some reason, a halt-report should be submitted actively within two months it happens.
Contacting window	If there is any questions, please contact the IRB. Tel: 05-2648000 ext: 5908 Fax: 05-2648000 ext:5916 Email: irb_DL@tzuchi.com.tw or mail to IRB of Dalin Tzu Chi General Hospital, 2, Min-Sheng Road, Dalin Town, Chia-Yi Taiwan R.O.C (622)
Chairman/Agency	Signed

Formally Released on Feb. 20, Minguo 101(2012)

Office-head letter of Buddhist Dalin Tzu Chi General Hospital

Approval Letter of agreement on clinical trail

This letter is to confirm that the project “A Multi-Center International Hospital-Based Case-Control Study of Lymphoma in Asia(AsiaLymph): Taiwan Study Center” submitted by Dr. Yu-chieh Su has been approved by the Institutional Review Board of our hospital after reviewing. Our IRB fulfills and abides by the “Regulation on Human Research” released on December 28, Minguo 100.

IRB of Dalin Tzu Chi General Hospital

Chairman

Feb. 20, Minguo 101 (Feb. 20, 2012)